 |
市場調査レポート
商品コード
1373797
生体電気医療の世界市場 (2023-2030年)：タイプ (埋め込み型電気医療デバイス・非侵襲的電気医療デバイス)・最終用途 (病院・その他) 別の規模・シェア・成長分析・予測Global Bioelectric Medicine Market Size, Share, Growth Analysis, By Type (Implantable electroceutical devices and non-invasive electroceutical devices), By End use(Hospitals and others) - Industry Forecast 2023-2030 |
||||||
| 生体電気医療の世界市場 (2023-2030年)：タイプ (埋め込み型電気医療デバイス・非侵襲的電気医療デバイス)・最終用途 (病院・その他) 別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月19日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の生体電気医療の市場規模は、2021年の201億米ドル、2022年の212億7,000万米ドルから、予測期間中は5.8%のCAGRで推移し、2030年には333億9,000万米ドルの規模に成長すると予測されています。
世界の生体電気医療の市場は、医療技術の進歩と神経調節の研究努力の増加により、近年大きな成長を遂げています。その成長の推進要因となっているのは、標準的な治療法で対応しきれない神経疾患、心血管疾患、慢性疼痛などの慢性疾患の有病率の増加であり、これらがアンメットメディカルニーズを生み出しています。生体電気医療は、他の選択肢を使い果たした患者に非侵襲的または低侵襲的なソリューションを提供し、転帰と生活の質を改善する可能性を示しています。
技術の進歩
デバイスの小型化、電池の寿命の延長、ワイヤレス接続、高度なアルゴリズムなどに象徴される医療技術の進化が生体電気医療の視野を大きく広げました。これらの技術革新は、生体電気デバイスと治療の精度と効率を高めるだけでなく、使いやすさも向上させ、市場拡大を後押ししています。
非侵襲的治療への需要の高まり
最小侵襲性、副作用の低減、自宅や外来での使用の適性から、非侵襲性治療に対する需要が高まっており、生体電気医療市場の成長に拍車をかけています。TENSユニットやTMSデバイスのような非侵襲的な電気治療デバイスが普及しつつあり、この拡大において重要な役割を果たしています。
当レポートでは、世界の生体電気医療の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の生体電気医療市場：タイプ別
- 市場概要
- 埋め込み型電気医療デバイス
- 非侵襲的電気医療デバイス
- 世界の生体電気医療市場：最終用途別
- 市場概要
- 病院
- その他
- 世界の生体電気医療市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- 上位5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corp
- electroCore LLC
- LivaNova PLC
- Inspire Medical Systems
- Second Sight Medical Products
- Soterix Medical
- NeuroMetrix
- BioControl Medical
- EnteroMedics Inc.
- MicroTransponder
- NDI Medical
- NeuroPace Inc.
- SetPoint Medical
- Galvani Bioelectronics
- Neuronetics Inc.
- Zynex Medical
- Cerbomed GmbH
Global Bioelectric Medicine Market size was valued at USD 20.1 Billion in 2021 and is poised to grow from USD 21.27 Billion in 2022 to USD 33.39 Billion by 2030, at a CAGR of 5.8% during the forecast period (2023-2030).
The global Bioelectric Medicine market has witnessed substantial growth recently, attributed to advancements in medical technology and increased research efforts in neuromodulation. Bioelectric medicine, or electroceuticals, employs electrical impulses to modulate the nervous system for therapeutic purposes, offering an innovative alternative to conventional pharmaceutical treatments. Its growth is fueled by the growing prevalence of chronic diseases, including neurological disorders, cardiovascular conditions, and chronic pain, which often resist standard therapies, resulting in unmet medical needs. Bioelectric medicine offers a non-invasive or minimally invasive solution for patients who have exhausted other options, potentially improving outcomes and quality of life. Furthermore, technological progress in bioelectric devices and implantable technologies has expanded the potential for targeted therapies.
Top-down and bottom-up approaches were used to estimate and validate the size of the global bioelectric medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
The global bioelectric medicine market is segmented on the basis of type, end use, and region. By type, the market is segmented into implantable electroceutical devices and non-invasive electroceutical devices. By end use, the market is segmented into hospitals and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers:
Technological Advancements
The evolution of medical technology, marked by the miniaturization of devices, extended battery life, wireless connectivity, and the emergence of advanced algorithms, has greatly broadened the horizons of bioelectric medicine. These innovations not only increase the precision and efficiency of bioelectric devices and treatments but also improve their user-friendliness, thus propelling market expansion.
Growing Demand for Non-Invasive Treatments
The increasing demand for non-invasive treatments, driven by their minimal invasiveness, decreased side effects, and suitability for home or outpatient use, is fueling the growth of the bioelectric medicine market. Non-invasive electroceutical devices like TENS units and TMS devices are becoming more popular and playing a key role in this expansion.
Restraints:
Stringent Regulatory Environment
Navigating the regulatory approval process for bioelectric medicine technologies can be a convoluted and protracted journey, as stringent criteria for safety, effectiveness, and quality must be met before obtaining approvals from regulatory authorities. The arduous compliance with these standards can present formidable obstacles, leading to protracted market entry timelines for innovative products in this field.
High Development and Manufacturing Costs
The substantial financial commitments required for the creation, production, and integration of bioelectric devices pose a formidable hurdle for smaller enterprises and emerging startups seeking to enter the market. The considerable expenses linked to activities such as research and development, clinical trials, and manufacturing can deter their participation in this field.
Market Trends:
The incorporation of bioelectric medicine into telemedicine and digital health solutions is broadening healthcare accessibility while enhancing patient supervision and post-treatment care. Increasingly, remote programming of implantable devices, teleconsultations, and digital platforms for patient education and support are becoming standard practices in the field of bioelectric medicine.
The field of bioelectric medicine is witnessing a substantial influx of investment and funding, with venture capital firms, government agencies, and strategic investors showing growing interest. This heightened awareness of the potential advantages of bioelectric medicine treatments is spurring financial support for research, development, clinical trials, and commercialization initiatives.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Bioelectric Medicine Market by Type
- Market Overview
- Implantable electroceutical devices and non-invasive electroceutical devices
- Global Bioelectric Medicine Market by End use
- Market Overview
- Hospitals and others
- Global Bioelectric Medicine Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic PLC - Ireland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- electroCore LLC - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC - UK
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inspire Medical Systems - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Second Sight Medical Products - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Soterix Medical - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroMetrix - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioControl Medical - Israel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EnteroMedics Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroTransponder - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NDI Medical - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SetPoint Medical - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galvani Bioelectronics - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neuronetics Inc. - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zynex Medical - US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cerbomed GmbH - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
